Prostate Cancer Prevention
Springer Berlin (Verlag)
978-3-642-45194-2 (ISBN)
Biology and natural history of prostate cancer.- Nutrition and prostate cancer.- Prostate cancer chemoprevention.- Lifestyle and dietary factors.- GWAS in prostate cancer predisposition and application to screening and prevention.- Risk prediction biomarkers - CCP.- Risk prediction biomarkers - TMPRSS2-ERG.- Risk prediction biomarkers - PCA3.- Risk adapted chemoprevention for PCa.- Outlook for 5 reductase inhibitors in prostate cancer prevention.- Prostate cancer chemoprevention: Aspirin.- Prostate cancer chemoprevention: DFMO.- Prostate cancer chemoprevention: Lycopene.- Distinguishing aggressive from indolent prostate cancer.- Prognosis and Management of low grade disease - Management of Gleason 6.- Prostate cancer prevention: Policy & Research implications.
From the reviews:
"Part of the Recent Advances in Cancer Research series, this book's title suggests that it tackles prevention of prostate cancer. ... scientists and clinicians who deal with prostate cancer are the main audience. ... The discussion of agent development and strategies is very useful to anyone looking to tackle the challenging area of prostate cancer chemoprevention." (Leonard G. Gomella, Doody's Book Reviews, May, 2014)
Erscheint lt. Verlag | 3.3.2014 |
---|---|
Reihe/Serie | Recent Results in Cancer Research |
Zusatzinfo | VIII, 169 p. 11 illus., 4 illus. in color. |
Verlagsort | Berlin |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 438 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
Schlagworte | Biomarkers • chemoprevention • early detection • Prostate Cancer • Risk-prevention |
ISBN-10 | 3-642-45194-2 / 3642451942 |
ISBN-13 | 978-3-642-45194-2 / 9783642451942 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich